|
1
|
Weitz J, Koch M, Debus J, Höhler T, Galle
PR and Büchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar
|
|
2
|
O’Connell JB, Maggard MA and Ko CY: Colon
cancer survival rates with the new American Joint Committee on
Cancer 6th edition staging. J Natl Cancer Inst. 96:1420–1425.
2004.
|
|
3
|
No authors listed. Efficacy of adjuvant
fluorouracil and folinic acid in B2 colon cancer. International
Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2)
Investigators. J Clin Oncol. 17:1356–1363. 1999.
|
|
4
|
No authors listed. Efficacy of adjuvant
fluorouracil and folinic acid in colon cancer. International
Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT)
investigators. Lancet. 345:939–944. 1995. View Article : Google Scholar
|
|
5
|
Wu H, Neilson JR, Kumar P, et al: miRNA
profiling of naïve, effector and memory CD8 T cells. PLoS One.
2:e10202007.
|
|
6
|
Wiemer EA: The role of microRNAs in
cancer: no small matter. Eur J Cancer. 43:1529–1544. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
9
|
Michael MZ, O’ Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
10
|
Cummins JM, He Y, Leary RJ, et al: The
colorectal microRNAome. Proc Natl Acad Sci USA. 103:3687–3692.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bandrés E, Cubedo E, Agirre X, et al:
Identification by real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissues. Mol Cancer. 5:292006.PubMed/NCBI
|
|
12
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar
|
|
13
|
Ma J, Dong C and Ji C: MicroRNA and drug
resistance. Cancer Gene Ther. 17:523–531. 2010. View Article : Google Scholar
|
|
14
|
Hurst DR, Edmonds MD and Welch DR:
Metastamir: the field of metastasis-regulatory microRNA is
spreading. Cancer Res. 69:7495–7498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang H, Li Y and Lai M: The microRNA
network and tumor metastasis. Oncogene. 29:937–948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weber JA, Baxter DH, Zhang S, et al: The
microRNA spectrum in 12 body fluids. Clin Chem. 56:1733–1741. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen X, Ba Y, Ma L, et al:
Characterization of microRNAs in serum: a novel class of biomarkers
for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kosaka N, Iguchi H, Yoshioka Y, Takeshita
F, Matsuki Y and Ochiya T: Secretory mechanisms and intercellular
transfer of microRNAs in living cells. J Biol Chem.
285:17442–17452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ritchie ME, Silver J, Oshlack A, et al: A
comparison of background correction methods for two-colour
microarrays. Bioinformatics. 23:2700–2707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article 3. 2004.PubMed/NCBI
|
|
23
|
Gentleman RC, Carey VJ, Bates DM, et al:
Bioconductor: open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Benjamini Y, Drai D, Elmer G, Kafkafi N
and Golani I: Controlling the false discovery rate in behavior
genetics research. Behav Brain Res. 125:279–284. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ng EK, Chong WW, Jin H, et al:
Differential expression of microRNAs in plasma of patients with
colorectal cancer: a potential marker for colorectal cancer
screening. Gut. 58:1375–1381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang Z, Huang D, Ni S, Peng Z, Sheng W
and Du X: Plasma microRNAs are promising novel biomarkers for early
detection of colorectal cancer. Int J Cancer. 127:118–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsang WP and Kwok TT: The
miR-18a* microRNA functions as a potential tumor
suppressor by targeting on K-Ras. Carcinogenesis. 30:953–959.
2009.PubMed/NCBI
|
|
29
|
Morimura R, Komatsu S, Ichikawa D, et al:
Novel diagnostic value of circulating miR-18a in plasma of patients
with pancreatic cancer. Br J Cancer. 105:1733–1740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weissmann-Brenner A, Kushnir M, Lithwick
Yanai G, et al: Tumor microRNA-29a expression and the risk of
recurrence in stage II colon cancer. Int J Oncol. 40:2097–2103.
2012.PubMed/NCBI
|
|
31
|
Wang LG and Gu J: Serum microRNA-29a is a
promising novel marker for early detection of colorectal liver
metastasis. Cancer Epidemiol. 36:e61–e67. 2012. View Article : Google Scholar : PubMed/NCBI
|
